AI is transforming healthcare engagement at unprecedented speed. Here's what most organizations are missing: automation without cultural intelligence creates irrelevance, inequity, and missed opportunity. With over 40% of Americans identifying as multicultural, our groundbreaking white paper reveals how the convergence of AI and cultural intelligence is reshaping patient engagement and why brands that master this intersection will own the future of […]
The FDA 9/9 letters reshaped DTC advertising. Three months later the real impact is emerging, from ad pauses to pushback on net impression claims. On September 9 the FDA issued 27 untitled letters to pharma companies over allegedly misleading television ads. We reviewed what has actually happened to the DTC efforts of those cited brands. […]
“When you talk to a doctor or a lawyer, there's medical privileges, legal privileges. There's no current concept of that when you talk to an AI, but maybe there should be.” —Sam Altman, The Atlantic (2024) Take it from the CEO of OpenAI: Confidentiality and privacy protections are among the biggest unresolved issues for those […]
If the FDA’s targeting of TV ads and social media influencers makes one thing clear, it’s that the biopharma industry is under the microscope. Promotions once considered “safe” are now fair game for untitled letters, warning letters and cease-and-desists. Understanding this new environment matters, but it is not the real story. The real story is […]
